Supporting a CAR-T Therapy for Multiple Myeloma with Integrated Laboratory Testing and Clinical Expertise

An emerging biotech sponsor chose Labcorp to support clinical testing and trials in their early-phase multiple myeloma study with a novel CAR-T therapy. Learn how the sponsor extended their team's expertise - through the Labcorp multiple myeloma team and CAR-T working group - and recognized the benefits of an integrated approach that united both laboratory services and clinical trial support to increase transparency and gain efficiencies across their portfolio.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/casestudies/Supporting-CAR-T-Therapy-for-Multiple-Myeloma-CSCLS034.pdf